当前位置: 首页 > 科室导航 > 内科科室 > 神经内科
专家介绍
姓    名:
曹勇军
最高学历:
博士
性    别:
科    室:
神经内科
教学职称:
副教授
行政职务:
科副主任
卫生职务:
主任医师
导师类别:
博士生导师
专家门诊:
周一全天,周三上午高级门诊
擅长疾病
率领卒中团队坚持脑血管病临床诊疗特色,2007年开展静脉溶栓,2008年组建介入团队,2010年成立规范化卒中病房,在卒中绿色通道管理及综合救治方面有丰富的经验。临床:擅长脑血管病的规范化诊疗:包括脑血管病急性期再通治疗、重症脑血管病综合救治、少见脑血管病的病因筛查、中风危险因素筛查与控制等。神经系统少见病、疑难病诊治。基础:脑缺血再灌注损伤和脑动脉粥样硬化炎性发病机制研究。重点关注纤维蛋白原、氧化低密度脂蛋白以及放射性损伤与动脉粥样硬化的关系。
个人简介
学习简历:
1996.07:安徽医科大学临床医学专业;
2001.07:获兰州大学医学硕士学位;
2007.06:获苏州大学医学博士学位。
工作简历:
2001.08-2004.08:东南大学医学院附属马鞍山市人民医院神经内科;
2007.08-----至今:苏州大学附属第二医院神经内科;
2009.09-2009.12:北京天坛医院卒中单元进修学习;
2015.04-2016.05:澳大利亚悉尼大学乔治研究院(TGI)及皇家阿弗莱德王子医院(RPAH)访问学者。
学术任职

1.中国卒中学会青年理事会常务理事;
2.中国研究型医院学会神经科学专业委员会委员;
3.中国医师协会神经病学分会脑血管病专委会委员;
4.江苏省卒中学会常务委员;省医学会脑卒中分会委员;
5.苏州市神经病学分会副主任委员、脑血管病学组组长、青委会主任委员;
6.国家自然科学基金同行评审专家;
7.《国际脑血管病杂志》编委;
8.《Stroke & Vascular Neurology》审稿人。

科研情况
1.         论文“the Effects of Antiplatelet Agents on Platelet-leukocyte Aggregations in Patients with Actue Cerebral Infarction”获2008-2009年度“苏州市自然科学优秀学术论文一等奖”;(排名第1
2.         临床研究“检测急性缺血性脑卒中患者中血小板-白细胞聚集体的变化:评价血小板活化的敏感指标”获2007-2008年度“苏州市新技术引进一等奖以及江苏省卫生厅新技术引进二等奖”;(均排名第1
3.         2009年获天坛国际脑血管会议颁发的“BI中国卒中研究奖”1次;(全国共3人)
4.         2014-2015年度“苏州大学以及江苏省优秀硕士学位论文”指导老师。
学术论文&在研项目

 主持参与国家自然基金3项;发表论文200余篇,其中被SCI期刊收录50余篇;培养研究生25名。
第一作者或通讯作者论著:
[1]Cao YJ?, Wang YM,Liu CF.The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with actue cerebral infarction.J Thromb Thrombolys.2009,27:233-238.
[2]Zhang X, Xiao GD, Xu XS, Zhang CY,Liu CF, Cao YJ.A case report and DSA fndings of cerebral hemorrhage caused by syphilitic vasculitis.Neurol Sci.2012,33(6):1411-1414.(Corresponding author)
[3]Xiao G,Sun T,Songming C,Cao Y.NR4A1 enhances neural survival following oxygen and glucose deprivation: An in vitro study.J Neurol Sci.2013,330(1-2) :78-84.(Corresponding author)
[4]Cao YJ,Zhou XM,Liu HH,Zhang YL,Yu XY,Liu CF.The NF-?B pathway: regulation of the instability of atherosclerotic plaques activated by Fg, Fb, and FDPs.Mol Cell Biochem.2013;383:29-37.
[5]Cao YJ,Zhang X,Liu CF,et al.Oral fibrinogen-depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel-group and controlled clinical trial.Chin Med J. 2013;126 (21) :4060-4065.
[6]Xu J,Cao Y. Radiation-induced carotid artery stenosis: a comprehensive review of the literature. Interv Neurol. 2014; 2(4):183-192. (Corresponding author)
[7]Zhou XM, Cao YJ, Ao GZ, Hu LF, Liu H, Wu J, Wang XY, Jin MM, Zheng SL, Zhen XC, Alkayed NJ,Jia J, Cheng J. CaMKKβ-dependent activation of AMP-activated kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation. Antioxidants & Redox Signaling. 2014;21(12):1741-1758.(First co-author)
[8]Zhang X, Huang ZC, Lu TS, You SJ, Cao YJ, Liu CF. Prognostic significience of uric acid levels in ischemic stroke patients. Neurotox Res. 2016;29(1):10-20.(Corresponding author)
[9]Xu JP, Shi JJ, Xiao GD, Duan GX, Zhang CY, Cao YJ.Endovascular Treatment of a Distal C1 Dissecting Aneurysm in a Patient with Double Aortic Arch.Chin Med J. 2016;129(1) :112-113.(Corresponding author)
[10]Zhang YL,Sun JJ, Yu XY,Cao YJ. SIRT1 regulates accumulation of oxidized LDL in HUVEC via the autophagy-lysosomal pathway. Prostaglandins & Other Lipid Mediators. 2016;122:37-44.(Corresponding author)
[11]You SJ, Han Q, Xu JP, Zhong CK, Zhang Y, Liu HH, Zhang YL, Xu XS, Liu CF,Cao YJ. Serum Calcium and Phosphate Levels and Short- and Long-Term Outcomes in Acute Intracerebral Hemorrhage Patients. J Stroke Cerebrovasc Dis.2016;25(4) :914-920.(Corresponding author)
[12]Duan G, Xu J, Shi J, Cao Y. Advances in the pathogenesis, diagnosis and treatment of bow hunter's syndrome: a comprehensive review of the literature. Interv Neurol. 2016; 5(1-2):29-38.(Corresponding author)
[13]Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee TH,Broderick JP, Chen X, Chen G, Sharma VK, Kim JS, Thang NH, Cao Y, Parsons MW, Levi C, Huang Y, Olavarria VV, Demchuk AM, Bath PM,Donnan GA, Martins S, Pontes?Neto OM, Silva F, Ricci S, Roffe C,Pandian J, Billot L, Woodward M, Li Q, Wang X, Wang J, and Chalmers J, for the ENCHANTED Investigators and Coordinators. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke. N Engl J Med. 2016 ;374(24):2313-2323. 
[14]Cao Y, Wang X, Zheng D, Robinson T, Hong D, Richtering S,  Leong TH, Salam A, Anderson C, Hackett ML. Air Pressure, Humidity and Stroke Occurrence: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2016;13(7). pii: E675. doi: 10.3390/ijerph13070675.
[15]Wang X, Cao Y, Hong D, Zheng D, Richtering S, Sandset EC, Leong TH, Arima H, Islam S, Salam A, Anderson C, Robinson T, Hackett ML. Ambient Temperature and Stroke Occurrence:A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2016;13(7). pii: E698. doi: 10.3390/ijerph13070698.  (Corresponding author)
[16]You S, Zhong C, Xu J, Han Q, Zhang X, Liu H, Zhang Y, Shi J, Huang Z, Xiao G, Zhang C, Cao Y, Liu C. LDL-C/HDL-C ratio and risk of all-cause mortality in patients with intracerebral hemorrhage. Neurol Res. 2016;14:1-6.(Corresponding author)
[17]You S, Shi L, Zhong C, Xu J, Han Q, Zhang X, Liu H, Zhang Y, Shi J, Huang Z, Cao Y, Liu C.Prognostic Significance of Estimated Glomerular Filtration Rate and Cystatin C in Patients with Acute Intracerebral Hemorrhage. Cerebrovasc Dis. 2016;42(5-6):455-463. (Corresponding author)
[18]You S, Zhong C, Zheng D, Xu J, Zhang X, Liu H, Zhang Y, Shi J, Huang Z, Cao Y, LiuCF.Monocyte to HDL cholesterol ratio is associated with discharge and 3-month outcome in patientswith acute intracerebral hemorrhage. J Neurol Sci. 2017;372:157-161. (Corresponding author)
[19]Sun Y, You S, Zhong C, Huang Z, Hu L, Zhang X, Shi J, Cao Y, Liu CF. Neutrophil to lymphocyte ratio and the hematoma volume and stroke severity in acute intracerebral hemorrhage patients. Am J Emerg Med. 2017; 35(3):429-433.(Corresponding author)
[20]You S, Shi L, Zhong C, Du H, Zhang Y, Zheng D,Wang X, Qiu C, Zhao H, Cao Y, Liu C. Admission Low Magnesium Level Is Associated with In-Hospital Mortality in Acute Ischemic Stroke Patients. Cerebrovasc Dis. 2017;44(1-2):35-42. (Corresponding author)
[21]Shi J, Cao Y, You S, Huang Z, Zhang X, Liu H, Liu CF. Yong stroke patients treated with intravenous thrombolysis have a more favorable outcome and mortality compared with older patients. Curr Neurovasc Res. 2017;14(2):141-148.(Corresponding author)
[22]Bei HZ, You SJ, Zheng D, Zhong CK, Du HP, Zhang Y, Lu TS, Cao LD, Dong XF, Cao YJ.Liu CF. Prognostic role of hypochloremia in acute ischemic stroke patients. Acta Neurol Scand. 2017;136(6):672-679.(Corresponding author)
[23]You S, Yin X, Liu H, Zheng D, Zhong C, Du H, Zhang Y, Zhao H, Qiu C, Fan L, Pei S, Ma Z, Cao Y, Liu CF. Hyperfibrinogenemia and in-hospital mortality in acute ischemic stroke patients.Curr Neurovasc Res. 2017;14(3):242-249.(Corresponding author)
[24]Xu JP, Shi JJ, Duan GX, Cao YJ. Imaging Features of Symptomatic Radiation-induced Cervical Artery Stenosis. Chin Med J. 2017;130:1876-1877. (Corresponding author)
[25]You S, Zheng D, Zhong C, Wang X, Tang W, Sheng L, Zheng C, Cao Y, Liu CF. Prognostic Significance of Blood Urea Nitrogen in Acute Ischemic Stroke. Circ J. 2018;82(2): 572-578.(Corresponding author)
[26]Sun JJ, Yin XW, Liu HH, Du WX, Shi LY, Huang YB, Wang F, Liu CF, Cao YJ, Zhang YL.Rapamycin inhibits ox-LDL-induced inflammation in human endothelial cells in vitro by inhibiting the mTORC2/PKC/c-Fos pathway. Acta Pharmacol Sin. 2018;39(3): 336-344.(Corresponding author)
[27]Shi J,Peng H,You S,Liu Y,Xu J,Xu Y,Liu H,Shi R,Cao Y,Liu CF. Increase in neutrophils after recombinant tissue plasminogen activator thrombolysis predictspoor functional outcome of ischaemic stroke: a longitudinal study. Eur J Neurol. 2018;25(4): 687-e45. (Corresponding author)
[28]You S, Saxena A, Wang X, Tan W, Han Q, Cao Y, Liu CF.Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.Stroke Vasc Neurol. 2018 ;3(1):22-27. (Corresponding author)
[29]Qu XY, Shi JJ, Cao YJ, Zhang MZ, Xu JP. Prognostic Value of White Blood Cell Counts and C-reactive Protein in Acute Ischemic Stroke Patients After Intravenous Thrombolysis. Current neurovascular research, 2018, 15:10-17. (Corresponding author)
 

友情链接:网站地图